Oramed Pharmaceuticals
ORMP
#9120
Rank
A$0.23 B
Marketcap
A$5.77
Share price
-3.12%
Change (1 day)
65.40%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): A$0.11 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of A$0.11 Billion, an increase over its 2024 earnings that were of -A$21.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.11 B7%
2025 A$0.11 B-616.9%
2024 -A$21.56 Million-311.47%
2023 A$10.19 M-119.45%
2022 -A$52.42 Million39.17%
2021 -A$37.66 Million73.93%
2020 -A$21.66 Million18.53%
2019 -A$18.27 Million-16.62%
2018 -A$21.91 Million38.32%
2017 -A$15.84 Million12.51%
2016 -A$14.08 Million25.01%
2015 -A$11.27 Million18.18%
2014 -A$9.53 Million39.72%
2013 -A$6.83 Million46.4%
2012 -A$4.66 Million128.32%
2011 -A$2.05 Million-51.47%
2010 -A$4.21 Million35.21%
2009 -A$3.11 Million
2007 -A$4.89 Million607.04%
2006 -A$0.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
A$35.78 B 31,672.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
A$10.95 B 9,628.39%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-A$0.77 Billion-781.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-A$37.34 Million-133.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
A$49.91 M-55.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel